If you have been consistent for two to three months and your pigment has not moved at all, this is the window where patience stops being the answer and reassessment starts being the answer. Something specific is likely stalling your progress, and identifying it is more useful than adding another product to the rotation.
This is not a failure. It is a diagnostic opportunity.
What should be happening by now
By eight to twelve weeks, surface-level PIH should be showing visible improvement. The marks should be lighter, softer at the edges, or less defined than they were at the start. Sun spots should be showing at least subtle shifts with consistent topical use. Melasma is the exception: three months is the minimum assessment window and subtle improvement is still a positive signal at this stage.
If nothing has changed, and you have genuinely been consistent (not on-and-off, not missing sun protection, not switching products every few weeks), then something in the equation is off. Here is where to look.
The diagnostic checklist
Work through these one at a time. Most stalls come down to one or two of these factors, not all of them.
Is the type identification correct? This is the most commonly missed variable. If you are treating PIH but the pigment is actually melasma, the timeline expectations are wrong and the approach may be mismatched. If you think you have sun spots but the pigment is hormonally driven, topicals alone may never move it. Understanding the type is the foundation everything else sits on. If you are unsure, this is a good reason to see a dermatologist for a definitive diagnosis.
Is the trigger still active? Fading cannot outrun active pigment production. If the breakouts are still happening, the friction is still ongoing, the inflammation is still running, or the UV exposure is uncontrolled, you are building new pigment as fast as you are trying to clear old pigment. The most effective intervention at this point might not be a better product. It might be resolving the source.
Is the approach matched to the pigment type? Different pigment types respond to different ingredients. A tyrosinase inhibitor might be the right move for sun spots but insufficient for melasma without trigger control. A retinoid might accelerate turnover for PIH but irritate melasma-prone skin. Matching the approach to the type is not just about choosing effective ingredients. It is about choosing the right ones for what you are specifically dealing with.
Is the barrier compromised? This is the sneaky one. If you have been using actives consistently for three months and your skin feels tight, sensitised, or reactive, your barrier may be compromised. A damaged barrier increases melanocyte reactivity (more pigment production) and reduces the effectiveness of topical ingredients (less absorption, less benefit). The paradox is that more effort can produce slower results when the barrier is paying the price.
Is sun protection adequate? Not "do you own sunscreen" but "are you applying it daily, reapplying during exposure, and protecting against visible light and heat, not just UV." Sun and heat exposure is the most common reason people feel their treatment stopped working. One unprotected afternoon can set back weeks of progress.
Is the pigment deeper than you think? Epidermal pigment responds to topicals and turnover. Dermal pigment does not. If the mark has a grey or blue-grey undertone, or if it has been there for years, there may be a dermal component that topicals cannot reach. A Wood's lamp assessment from a dermatologist can clarify this in minutes.
What to do next
If you identified the likely stall factor, address that specific thing before changing anything else. Most people default to adding products when the real issue is removing a barrier to progress, whether that is a trigger, barrier damage, sun exposure, or a type mismatch.
If you have worked through the checklist and nothing obvious stands out, or if multiple factors seem to apply, a dermatologist visit is the most efficient next step. They can confirm the pigment type, assess depth, check your barrier, and recommend adjustments based on what they actually see rather than what a product label promises.
The goal at this stage is precision, not escalation. The answer is rarely "more." It is almost always "different" or "better matched."
At eight to twelve weeks, the question shifts from "is this working" to "what specifically is in the way." Find the stall factor, address it, and the progress usually follows.
